Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
4DMedical Ltd ( (AU:4DX) ) has issued an update.
4DMedical Ltd has announced the quotation of new securities on the ASX, specifically piggyback options issued upon the exercise of previously listed options. This development involves the issuance of 2,872,980 options set to expire on September 1, 2027. The move is part of the company’s strategic financial operations, potentially impacting its market presence and offering stakeholders an opportunity for investment growth.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd is a company operating in the medical technology industry, focusing on developing advanced respiratory imaging solutions. The company is known for its innovative products that aim to enhance the diagnosis and treatment of respiratory conditions, positioning itself as a leader in the healthcare technology market.
Average Trading Volume: 6,041,673
Technical Sentiment Signal: Buy
Current Market Cap: A$752.1M
See more data about 4DX stock on TipRanks’ Stock Analysis page.